2,568
Views
6
CrossRef citations to date
0
Altmetric
Addendum

Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases

, , , , , , , , , , (for the UK Brain Expression Consortium (UKBEC)) , , , & show all
Article: e1198458 | Received 22 Feb 2016, Accepted 01 Jun 2016, Published online: 07 Jul 2016

References

  • Gregory A, Hayflick S. Neurodegeneration with Brain Iron Accumulation Disorders Overview. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, eds. GeneReviews(R). Seattle WA: University of Washington, Seattle, 1993
  • Johnstone D, Milward EA. Molecular genetic approaches to understanding the roles and regulation of iron in brain health and disease. J Neurochem 2010; 113:1387-402; PMID:20345752
  • Delima RD, Chua AC, Tirnitz-Parker JE, Gan EK, Croft KD, Graham RM, Olynyk JK, Trinder D. Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice. Hepatology 2012; 56:585-93; PMID:22383097; http://dx.doi.org/10.1002/hep.25689
  • Heidari M, Johnstone DM, Bassett B, Graham RM, Chua ACG, House MJ, Collingwood JF, Bettencourt C, Houlden H, Ryten M, et al. Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features. Mol Psychiatry 2016; PMID:26728570; http://www.nature.com/mp/journal/vaop/ncurrent/full/mp2015192a.html
  • Johnstone D, Milward EA. Genome-wide microarray analysis of brain gene expression in mice on a short-term high iron diet. Neurochem Int 2010; 56:856-63; PMID:20350576; http://dx.doi.org/10.1016/j.neuint.2010.03.015
  • Acikyol B, Graham RM, Trinder D, House MJ, Olynyk JK, Scott RJ, Milward EA, Johnstone DM. Brain transcriptome perturbations in the transferrin receptor 2 mutant mouse support the case for brain changes in iron loading disorders, including effects relating to long-term depression and long-term potentiation. Neuroscience 2013; 235:119-28; PMID:23333676; http://dx.doi.org/10.1016/j.neuroscience.2013.01.014
  • Johnstone D, Graham RM, Trinder D, Delima RD, Riveros C, Olynyk JK, Scott RJ, Moscato P, Milward EA. Brain transcriptome perturbations in the Hfe(−/−) mouse model of genetic iron loading. Brain Res 2012; 1448:144-52; PMID:22370144; http://dx.doi.org/10.1016/j.brainres.2012.02.006
  • Johnstone D, Riveros C, Heidari M, Graham R, Trinder D, Berretta R, Olynyk J, Scott R, Moscato P, Milward E. Evaluation of Different Normalization and Analysis Procedures for Illumina Gene Expression Microarray Data Involving Small Changes. Microarray. 2013; 2:131-52; http://www.mdpi.com/2076-3905/2/2/131
  • Bettencourt C, Forabosco P, Wiethoff S, Heidari M, Johnstone DM, Botia JA, Collingwood JF, Hardy J, Milward EA, Ryten M, et al. Gene co-expression networks shed light into diseases of brain iron accumulation. Neurobiol Dis 2016; 87:59-68; PMID:26707700; http://dx.doi.org/10.1016/j.nbd.2015.12.004
  • Bhatia KP, Schneider S. Metal Related Neurodegenerative Disease. Int Rev Neurobiol. London, UK: Academic Press, 2013; 434
  • Li A, Paudel R, Johnson R, Courtney R, Lees AJ, Holton JL, Hardy J, Revesz T, Houlden H. Pantothenate kinase-associated neurodegeneration is not a synucleinopathy. Neuropathol Appl Neurobiol 2013; 39:121-31; PMID:22416811; http://dx.doi.org/10.1111/j.1365-2990.2012.01269.x
  • Zhao L, Hadziahmetovic M, Wang C, Xu X, Song Y, Jinnah HA, Wodzinska J, Iacovelli J, Wolkow N, Krajacic P, et al. Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone. J Neurochem 2015; 135(5):958-74
  • Schulz K, Vulpe CD, Harris LZ, David S. Iron efflux from oligodendrocytes is differentially regulated in gray and white matter. J Neurosci 2011; 31:13301-11; PMID:21917813; http://dx.doi.org/10.1523/JNEUROSCI.2838-11.2011
  • Alazami AM, Schneider SA, Bonneau D, Pasquier L, Carecchio M, Kojovic M, Steindl K, de Kerdanet M, Nezarati MM, Bhatia KP, et al. C2orf37 mutational spectrum in Woodhouse-Sakati syndrome patients. Clin Genet 2010; 78:585-90; PMID:20507343; http://dx.doi.org/10.1111/j.1399-0004.2010.01441.x
  • Ben-Omran T, Ali R, Almureikhi M, Alameer S, Al-Saffar M, Walsh CA, Felie JM, Teebi A. Phenotypic heterogeneity in Woodhouse-Sakati syndrome: two new families with a mutation in the C2orf37 gene. Am J Med Genet A 2011; 155A:2647-53; PMID:21964978; http://dx.doi.org/10.1002/ajmg.a.34219
  • Okamoto N, Ikeda T, Hasegawa T, Yamamoto Y, Kawato K, Komoto T, Imoto I. Early manifestations of BPAN in a pediatric patient. Am J Med Genet A 2014; 164:3095-9; http://dx.doi.org/10.1002/ajmg.a.36779
  • Rathore GS, Schaaf CP, Stocco AJ. Novel mutation of the WDR45 gene causing β-propeller protein-associated neurodegeneration. Mov Disord 2014; 29:574-5; PMID:24610255; http://dx.doi.org/10.1002/mds.25868
  • Drecourt A, Boddaert N, Desguerre I, Chretien D, Munnich A, Rotig A. REPS1 is a novel gene of Neurodegeneration with Brain Iron Accumulation. American Society of Human Genetics meeting. Boston, US, 2013
  • Wouthuis SF, van Deursen CT, te Lintelo MP, Rozeman CA, Beekman R. Neuromuscular manifestations in hereditary haemochromatosis. J Neurol 2010; 257:1465-72; PMID:20358215; http://dx.doi.org/10.1007/s00415-010-5548-x
  • Shen MR, Chou CY, Hsu KF, Liu HS, Dunham PB, Holtzman EJ, Ellory JC. The KCl cotransporter isoform KCC3 can play an important role in cell growth regulation. Proc Natl Acad Sci U S A 2001; 98:14714-9; PMID:11724933; http://dx.doi.org/10.1073/pnas.251388798
  • Dupre N, Howard HC, Rouleau GA. Hereditary Motor and Sensory Neuropathy with Agenesis of the Corpus Callosum. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, et al., eds. GeneReviews(R). Seattle University of Washington, 1993
  • Chateau MT, Araiz C, Descamps S, Galas S. Klotho interferes with a novel FGF-signalling pathway and insulin/Igf-like signalling to improve longevity and stress resistance in Caenorhabditis elegans. Aging 2010; 2:567-81; PMID:20844315; http://dx.doi.org/10.18632/aging.100195
  • Brobey RK, German D, Sonsalla PK, Gurnani P, Pastor J, Hsieh CC, Papaconstantinou J, Foster PP, Kuro-o M, Rosenblatt KP. Klotho Protects Dopaminergic Neuron Oxidant-Induced Degeneration by Modulating ASK1 and p38 MAPK Signaling Pathways. PloS one 2015; 10:e0139914; PMID:26452228; http://dx.doi.org/10.1371/journal.pone.0139914
  • Zeldich E, Chen CD, Colvin TA, Bove-Fenderson EA, Liang J, Tucker Zhou TB, Harris DA, Abraham CR. The neuroprotective effect of Klotho is mediated via regulation of members of the redox system. J Biol Chem 2014; 289:24700-15; PMID:25037225; http://dx.doi.org/10.1074/jbc.M114.567321
  • Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390:45-51; PMID:9363890; http://dx.doi.org/10.1038/36285
  • Razzaque MS, Sitara D, Taguchi T, St-Arnaud R, Lanske B. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 2006; 20:720-2; PMID:16436465
  • Sun JJ, Ren QG, Xu L, Zhang ZJ. LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice. Sci Rep 2015; 5:14235; PMID:26383267; http://dx.doi.org/10.1038/srep14235
  • Saher G, Brugger B, Lappe-Siefke C, Mobius W, Tozawa R, Wehr MC, Wieland F, Ishibashi S, Nave KA. High cholesterol level is essential for myelin membrane growth. Nat Neurosci 2005; 8:468-75; PMID:15793579
  • Stevenson RE, Tarpey P, May MM, Stratton MR, Schwartz CE. Arena syndrome is caused by a missense mutation in PLP1. Am J Med Genet A 2009; 149A:1081; PMID:19396823; http://dx.doi.org/10.1002/ajmg.a.32795
  • Woodward K, Malcolm S. Proteolipid protein gene: Pelizaeus–Merzbacher disease in humans and neurodegeneration in mice. Trends Genet 1999; 15:125-8; PMID:10203813; http://dx.doi.org/10.1016/S0168-9525(99)01716-3